Stockreport

Eli Lilly: We Haven't Reached Its Peak Yet (Rating Upgrade) [Seeking Alpha]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF LLY's medium-term growth is anchored by obesity drugs Mounjaro and Zepbound, with Foundayo and the Kelonia acquisition as near-term catalysts. Consensus expects robus [Read more]